Skip to main content
. Author manuscript; available in PMC: 2021 Nov 1.
Published in final edited form as: Contraception. 2020 Aug 21;102(5):361–367. doi: 10.1016/j.contraception.2020.08.006

Table 1.

Accuracies, precisions (expressed as CVs), matrix effects, and recoveries for the simultaneous analysis of NES and endogenous steroid hormones (n=5).

Analyte Spiked Value (ng/mL) Expected Value (ng/mL) Assayed Value (ng/mL) Intra-assay CV Inter-assay CV  Accuracy Matrix Effect Recovery

Nestorone® QC1Nestorone® QC2 0.100 0.100 0.087 10.7% 14.0% 87.0% 93.2% 83.5%
Nestorone® QC2 0.500 0.500 0.480 11.1% 13.5% 96.0%

Estradiol QC1 0.000 0.124 0.122 5.8% 6.9% 98.4% 105.9% 92.8%
Estradiol QC2 0.500 0.624 0.621 6.0% 6.4% 99.5%

Progesterone QC1 0.000 3.530 3.706 12.6% 14.4% 105.0% 64.9% 84.4%
Progesterone QC2 0.500 4.030 4.048 14.0% 14.5% 100.4%

Estrone QC1 0.100 0.166 0.184 5.9% 6.9% 110.8% 102.5% 93.1%
Estrone QC2 0.500 0.566 0.574 5.8% 6.8% 101.4%

Expected values for QC1 and QC2 for Nestorone were created using spikes of unlabeled standard. Expected values for QC1 for estradiol and progesterone were endogenous values; expected values for QC2 for estradiol, progesterone, and estrone, as well as for QC1 for estrone, are the sum of endogenous and spiked amounts as listed in the table above. QC, quality control; CV, coefficient of variation.